Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1635947
PUBLISHER: IMARC | PRODUCT CODE: 1635947
Congestive Heart Failure Drugs Market by Drug Class, Route of Administration, Distribution Channel, and Region 2025-2033
PUBLISHED:
PAGES: 134 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global congestive heart failure drugs market size reached USD 9.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 24.5 Billion by 2033, exhibiting a growth rate (CAGR) of 10.62% during 2025-2033. The rising prevalence of obesity and cardiovascular problems, increasing geriatric population and unhealthy dietary habits represent some of the key factors driving the market.
Congestive heart failure is a medical condition that affects the pumping ability of the heart muscle. It is generally caused by hypertension, coronary artery disease, diabetes, obesity, and excessive alcohol consumption. Its symptoms include shortness of breath while lying down, weakness, fatigue, swelling in the abdomen, feet, and ankles, frequent urination at night, nausea, and difficulty in concentration. It can be prevented by maintaining a healthy weight, staying physically active, and controlling blood pressure and glycemic levels. Besides this, it is controlled using various prescribed drugs that help prevent blood clots, expand blood vessels, strengthen the contractions of the heart, and improve heart functioning. At present, ACE inhibitors, vasodilators, digitalis glycosides, diuretics, and beta-blockers are some of the most prescribed congestive heart failure drugs. Amongst these, ACE inhibitors prevent the formation of angiotensin, which causes blood vessels to constrict, and beta blockers block the actions of certain chemicals.
Presently, the increasing global geriatric population, which is highly susceptible to diabetes and chronic cardiovascular diseases, represents one of the major factors positively influencing the market. In addition, excessive smoking and drinking of alcoholic beverages, coupled with unhealthy dietary habits of individuals, increases the risks of heart problems, which is catalyzing the demand for congestive heart failure drugs across the globe. This, coupled with the rising occurrence of heart problems due to obesity and lack of physical activity, is currently strengthening the growth of the market. Furthermore, the increasing awareness among individuals about the benefits of early diagnosis and treatment of heart disease is creating a positive outlook for the market. Apart from this, the escalating demand for effective drugs and treatment and their approval from authorized agencies offer lucrative growth opportunities to the leading market players. Moreover, initiatives undertaken by governments of various countries to improve healthcare infrastructure and provide optimal care to patients are contributing to the growth of the market. Additionally, the expansion of pharmacies in hospitals and residential areas and the burgeoning e-commerce industry providing easy availability of medicines at affordable rates and the facility of secured online payment methods are expected to propel the growth of the market.
Key Market Segmentation:
Drug Class Insights:
- ACE Inhibitors
- Angiotensin 2 Receptor Blockers
- Beta Blockers
- Diuretics
- Aldosterone Antagonists
- Inotropes
- Others
- The report has also provided a detailed breakup and analysis of the congestive heart failure drugs market based on the drug class. This includes ACE inhibitors, angiotensin 2 receptor blockers, beta blockers, diuretics, aldosterone antagonists, inotropes, and others. According to the report, ACE inhibitors represented the largest segment.
Route of Administration Insights:
- Oral
- Intravenous
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
- The report has also provided a comprehensive analysis of all the major regional markets that include North America (The United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. According to the report, North America was the largest market for congestive heart failure drugs. Some of the factors driving the North America market included the development of healthcare infrastructure, increasing cases of heart failure and the easy availability of technologically advanced devices and innovative drugs.
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the global congestive heart failure drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG), Novartis AG, etc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1. How big is the global congestive heart failure drugs market?
- 2. What is the expected growth rate of the global congestive heart failure drugs market during 2025-2033?
- 3. What are the key factors driving the global congestive heart failure drugs market?
- 4. What has been the impact of COVID-19 on the global congestive heart failure drugs market?
- 5. What is the breakup of the global congestive heart failure drugs market based on the drug class?
- 6. What is the breakup of the global congestive heart failure drugs market based on the route of administration?
- 7. What is the breakup of the global congestive heart failure drugs market based on the distribution channel?
- 8. What are the key regions in the global congestive heart failure drugs market?
- 9. Who are the key players/companies in the global congestive heart failure drugs market?
Product Code: SR112025A6649
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Congestive Heart Failure Drugs Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Class
- 6.1 ACE Inhibitors
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Angiotensin 2 Receptor Blockers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Beta Blockers
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Diuretics
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Aldosterone Antagonists
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Inotropes
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
7 Market Breakup by Route of Administration
- 7.1 Oral
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Intravenous
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Online Pharmacies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 AstraZeneca plc
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Bayer AG
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn Ag & Co. KG)
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Novartis AG
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.1 AstraZeneca plc
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
Product Code: SR112025A6649
List of Figures
- Figure 1: Global: Congestive Heart Failure Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Congestive Heart Failure Drugs Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Congestive Heart Failure Drugs Market: Breakup by Drug Class (in %), 2024
- Figure 5: Global: Congestive Heart Failure Drugs Market: Breakup by Route of Administration (in %), 2024
- Figure 6: Global: Congestive Heart Failure Drugs Market: Breakup by Distribution Channel (in %), 2024
- Figure 7: Global: Congestive Heart Failure Drugs Market: Breakup by Region (in %), 2024
- Figure 8: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Congestive Heart Failure Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Congestive Heart Failure Drugs (Angiotensin 2 Receptor Blockers) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Congestive Heart Failure Drugs (Beta Blockers) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Congestive Heart Failure Drugs (Beta Blockers) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Congestive Heart Failure Drugs (Diuretics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Congestive Heart Failure Drugs (Diuretics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Congestive Heart Failure Drugs (Aldosterone Antagonists) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Congestive Heart Failure Drugs (Inotropes) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Congestive Heart Failure Drugs (Inotropes) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Congestive Heart Failure Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Congestive Heart Failure Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Congestive Heart Failure Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Congestive Heart Failure Drugs (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Congestive Heart Failure Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Congestive Heart Failure Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Congestive Heart Failure Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Congestive Heart Failure Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: North America: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: North America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: United States: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: United States: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Canada: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Canada: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Asia-Pacific: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Asia-Pacific: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: China: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: China: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Japan: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Japan: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: India: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: India: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: South Korea: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: South Korea: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Australia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Australia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Indonesia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Indonesia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Europe: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Europe: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Germany: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Germany: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: France: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: France: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: United Kingdom: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: United Kingdom: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Italy: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Italy: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Spain: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Spain: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Russia: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Russia: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Latin America: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Latin America: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Brazil: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Brazil: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Mexico: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Mexico: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Others: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Others: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Middle East and Africa: Congestive Heart Failure Drugs Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Middle East and Africa: Congestive Heart Failure Drugs Market: Breakup by Country (in %), 2024
- Figure 80: Middle East and Africa: Congestive Heart Failure Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Global: Congestive Heart Failure Drugs Industry: Drivers, Restraints, and Opportunities
- Figure 82: Global: Congestive Heart Failure Drugs Industry: Value Chain Analysis
- Figure 83: Global: Congestive Heart Failure Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Congestive Heart Failure Drugs Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
- Table 3: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
- Table 4: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 5: Global: Congestive Heart Failure Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Congestive Heart Failure Drugs Market: Competitive Structure
- Table 7: Global: Congestive Heart Failure Drugs Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.